STD Diagnostics-North America Market Status and Trend Report 2013-2023
Report Summary
STD Diagnostics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on STD Diagnostics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of STD Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of STD Diagnostics in North America, with company and product introduction, position in the STD Diagnostics market
Market status and development trend of STD Diagnostics by types and applications
Cost and profit status of STD Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the North America STD Diagnostics market as:
North America STD Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America STD Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
North America STD Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cinic
Other
North America STD Diagnostics Market: Players Segment Analysis (Company and Product introduction, STD Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Holdings AG
Abbott Laboratories
Becton Dickinson and Company
Hologic Inc
Danaher Corporation
Affymetrix
bioMerieux
Cepheid Inc
Alere Inc
DiaSorin
Orasure
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
STD Diagnostics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on STD Diagnostics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of STD Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of STD Diagnostics in North America, with company and product introduction, position in the STD Diagnostics market
Market status and development trend of STD Diagnostics by types and applications
Cost and profit status of STD Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the North America STD Diagnostics market as:
North America STD Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America STD Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
North America STD Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cinic
Other
North America STD Diagnostics Market: Players Segment Analysis (Company and Product introduction, STD Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Holdings AG
Abbott Laboratories
Becton Dickinson and Company
Hologic Inc
Danaher Corporation
Affymetrix
bioMerieux
Cepheid Inc
Alere Inc
DiaSorin
Orasure
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF STD DIAGNOSTICS
1.1 Definition of STD Diagnostics in This Report
1.2 Commercial Types of STD Diagnostics
1.2.1 Chlamydia Testing
1.2.2 Syphilis Testing
1.2.3 Gonorrhea Testing
1.2.4 Herpes Simplex Virus Testing
1.2.5 Human Papilloma Virus Testing
1.2.6 Human Immunodeficiency Virus Testing
1.2.7 Chancroid Testing
1.3 Downstream Application of STD Diagnostics
1.3.1 Hospital
1.3.2 Cinic
1.3.3 Other
1.4 Development History of STD Diagnostics
1.5 Market Status and Trend of STD Diagnostics 2013-2023
1.5.1 North America STD Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional STD Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of STD Diagnostics in North America 2013-2017
2.2 Consumption Market of STD Diagnostics in North America by Regions
2.2.1 Consumption Volume of STD Diagnostics in North America by Regions
2.2.2 Revenue of STD Diagnostics in North America by Regions
2.3 Market Analysis of STD Diagnostics in North America by Regions
2.3.1 Market Analysis of STD Diagnostics in United States 2013-2017
2.3.2 Market Analysis of STD Diagnostics in Canada 2013-2017
2.3.3 Market Analysis of STD Diagnostics in Mexico 2013-2017
2.4 Market Development Forecast of STD Diagnostics in North America 2018-2023
2.4.1 Market Development Forecast of STD Diagnostics in North America 2018-2023
2.4.2 Market Development Forecast of STD Diagnostics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of STD Diagnostics in North America by Types
3.1.2 Revenue of STD Diagnostics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of STD Diagnostics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of STD Diagnostics in North America by Downstream Industry
4.2 Demand Volume of STD Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of STD Diagnostics by Downstream Industry in United States
4.2.2 Demand Volume of STD Diagnostics by Downstream Industry in Canada
4.2.3 Demand Volume of STD Diagnostics by Downstream Industry in Mexico
4.3 Market Forecast of STD Diagnostics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF STD DIAGNOSTICS
5.1 North America Economy Situation and Trend Overview
5.2 STD Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 STD DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of STD Diagnostics in North America by Major Players
6.2 Revenue of STD Diagnostics in North America by Major Players
6.3 Basic Information of STD Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of STD Diagnostics Major Players
6.3.2 Employees and Revenue Level of STD Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 STD DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Holdings AG
7.1.1 Company profile
7.1.2 Representative STD Diagnostics Product
7.1.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Roche Holdings AG
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative STD Diagnostics Product
7.2.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Becton Dickinson and Company
7.3.1 Company profile
7.3.2 Representative STD Diagnostics Product
7.3.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson and Company
7.4 Hologic Inc
7.4.1 Company profile
7.4.2 Representative STD Diagnostics Product
7.4.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative STD Diagnostics Product
7.5.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Affymetrix
7.6.1 Company profile
7.6.2 Representative STD Diagnostics Product
7.6.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Affymetrix
7.7 bioMerieux
7.7.1 Company profile
7.7.2 Representative STD Diagnostics Product
7.7.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of bioMerieux
7.8 Cepheid Inc
7.8.1 Company profile
7.8.2 Representative STD Diagnostics Product
7.8.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid Inc
7.9 Alere Inc
7.9.1 Company profile
7.9.2 Representative STD Diagnostics Product
7.9.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc
7.10 DiaSorin
7.10.1 Company profile
7.10.2 Representative STD Diagnostics Product
7.10.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of DiaSorin
7.11 Orasure
7.11.1 Company profile
7.11.2 Representative STD Diagnostics Product
7.11.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Orasure
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF STD DIAGNOSTICS
8.1 Industry Chain of STD Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF STD DIAGNOSTICS
9.1 Cost Structure Analysis of STD Diagnostics
9.2 Raw Materials Cost Analysis of STD Diagnostics
9.3 Labor Cost Analysis of STD Diagnostics
9.4 Manufacturing Expenses Analysis of STD Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF STD DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of STD Diagnostics in This Report
1.2 Commercial Types of STD Diagnostics
1.2.1 Chlamydia Testing
1.2.2 Syphilis Testing
1.2.3 Gonorrhea Testing
1.2.4 Herpes Simplex Virus Testing
1.2.5 Human Papilloma Virus Testing
1.2.6 Human Immunodeficiency Virus Testing
1.2.7 Chancroid Testing
1.3 Downstream Application of STD Diagnostics
1.3.1 Hospital
1.3.2 Cinic
1.3.3 Other
1.4 Development History of STD Diagnostics
1.5 Market Status and Trend of STD Diagnostics 2013-2023
1.5.1 North America STD Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional STD Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of STD Diagnostics in North America 2013-2017
2.2 Consumption Market of STD Diagnostics in North America by Regions
2.2.1 Consumption Volume of STD Diagnostics in North America by Regions
2.2.2 Revenue of STD Diagnostics in North America by Regions
2.3 Market Analysis of STD Diagnostics in North America by Regions
2.3.1 Market Analysis of STD Diagnostics in United States 2013-2017
2.3.2 Market Analysis of STD Diagnostics in Canada 2013-2017
2.3.3 Market Analysis of STD Diagnostics in Mexico 2013-2017
2.4 Market Development Forecast of STD Diagnostics in North America 2018-2023
2.4.1 Market Development Forecast of STD Diagnostics in North America 2018-2023
2.4.2 Market Development Forecast of STD Diagnostics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of STD Diagnostics in North America by Types
3.1.2 Revenue of STD Diagnostics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of STD Diagnostics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of STD Diagnostics in North America by Downstream Industry
4.2 Demand Volume of STD Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of STD Diagnostics by Downstream Industry in United States
4.2.2 Demand Volume of STD Diagnostics by Downstream Industry in Canada
4.2.3 Demand Volume of STD Diagnostics by Downstream Industry in Mexico
4.3 Market Forecast of STD Diagnostics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF STD DIAGNOSTICS
5.1 North America Economy Situation and Trend Overview
5.2 STD Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 STD DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of STD Diagnostics in North America by Major Players
6.2 Revenue of STD Diagnostics in North America by Major Players
6.3 Basic Information of STD Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of STD Diagnostics Major Players
6.3.2 Employees and Revenue Level of STD Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 STD DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Holdings AG
7.1.1 Company profile
7.1.2 Representative STD Diagnostics Product
7.1.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Roche Holdings AG
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative STD Diagnostics Product
7.2.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Becton Dickinson and Company
7.3.1 Company profile
7.3.2 Representative STD Diagnostics Product
7.3.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Becton Dickinson and Company
7.4 Hologic Inc
7.4.1 Company profile
7.4.2 Representative STD Diagnostics Product
7.4.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.5 Danaher Corporation
7.5.1 Company profile
7.5.2 Representative STD Diagnostics Product
7.5.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
7.6 Affymetrix
7.6.1 Company profile
7.6.2 Representative STD Diagnostics Product
7.6.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Affymetrix
7.7 bioMerieux
7.7.1 Company profile
7.7.2 Representative STD Diagnostics Product
7.7.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of bioMerieux
7.8 Cepheid Inc
7.8.1 Company profile
7.8.2 Representative STD Diagnostics Product
7.8.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid Inc
7.9 Alere Inc
7.9.1 Company profile
7.9.2 Representative STD Diagnostics Product
7.9.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Alere Inc
7.10 DiaSorin
7.10.1 Company profile
7.10.2 Representative STD Diagnostics Product
7.10.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of DiaSorin
7.11 Orasure
7.11.1 Company profile
7.11.2 Representative STD Diagnostics Product
7.11.3 STD Diagnostics Sales, Revenue, Price and Gross Margin of Orasure
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF STD DIAGNOSTICS
8.1 Industry Chain of STD Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF STD DIAGNOSTICS
9.1 Cost Structure Analysis of STD Diagnostics
9.2 Raw Materials Cost Analysis of STD Diagnostics
9.3 Labor Cost Analysis of STD Diagnostics
9.4 Manufacturing Expenses Analysis of STD Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF STD DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
